ZGBEF yields 0.28% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, ZGBEF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZGBEF + MRK for your $10,000?
2G Energy AG, together with its subsidiaries, develops, manufactures, and installs combined heat and power (CHP) systems, and other systems for the recovery of electrical energy in Germany and internationally. It offers decentralized power and heat through gas motors driven by natural gas, biomethane, biogas, sewage gas, landfill gas, or hydrogen with an electrical output of 20 to 4,500 kW. The company's products include g-box, a natural gas CHP plant with the electrical output of 20 kW to 50 kW; aura, a CHP plant with the output range from 100 kW to 420 kW; patruus, a biogas and natural gas CHP plant with the output range from 50 kW to 263 kW; agenitor, a CHP plant with a capacity of 220 kW to 450 kW; and avus, a CHP plant with the electrical output range of 400 kW to 4.000 kW. It also engages in the rental and leasing of CHP plants. The company's products are used for various applications, such as biogas plants, office and administrative buildings, chemical and pharmaceutical industries, landfills, shopping centers, horticultural and agricultural holdings, hotels, industry and trade, sewage treatment plants, hospitals, food industry, public institutions, data processing centers, schools and universities, swimming pools, senior citizen centers, sports and leisure centers, heat grids, hydrogen, and residential buildings. The company was formerly known as 2G Bio-Energietechnik AG and changed its name to 2G Energy AG in 2011. 2G Energy AG was founded in 1995 and is headquartered in Heek, Germany.
Full ZGBEF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.